Target intelligence / Profile preview

Transformer-2 alpha pseudogene

Molecular classification
Other (pseudogene)
01

Overview

Transformer-2 alpha pseudogene (ENSG00000223429) is a non-coding genomic locus annotated as a pseudogene, likely derived from a former protein-coding transformer-2 alpha gene. Pseudogenes generally arise from gene duplication or retrotransposition; they accumulate mutations that disrupt their ability to encode a functional protein. Most do not produce functional RNA or protein, though rarely, transcribed pseudogenes may have regulatory effects, such as influencing expression of related protein-coding genes. There is no evidence that this specific pseudogene is a therapeutic target or is involved in clinically relevant mechanisms[1][2][3][4]. Key insights supporting this assessment: - Pseudogenes are distinct from protein-coding genes and typically lack functional products due to disabling mutations[1][2]. - They are classified separately from therapeutic targets; the majority lack translatable biological or disease-related function[1][3]. - "Transformer-2 alpha pseudogene" reflects its derivation from the transformer-2 alpha ancestral gene, but all evidence classifies it as non-functional[4]. - No known drug interactions, mechanisms, or biomarker utility exist for this locus[1][2][3][4]. This entry is therefore best classified as non-target, with "is_incorrect" marked true, because it is not a true therapeutic or biological target under standard classifications.

Other names
transformer 2 alpha pseudogenetransformer-2 alpha (pseudogene)transformer 2 alpha-like pseudogene
02

Biological functions

Other (no established protein function; may have regulatory effects at RNA level in rare cases)
03

Disease associations

Other (no established roles in disease)

Beyond the preview

Go deeper on Transformer-2 alpha pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transformer-2 alpha pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call